Skip Navigation

A Phase II Open Label Randomized Study of MORAb-202 an antibody drug conjugate versus Chemotherapy in Platinum Resistant Ovarian Cancer

Brief Summary

Type:
Ovarian

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05613088

Study #:
STUDY00149469

Start Date:
May 25, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05613088

View Complete Trial Details & Eligibility at ClinicalTrials.gov